Evolus (EOLS) Assets Average (2018 - 2026)
Evolus' (EOLS) quarterly Assets Average came in at $223.3 million in Q1 2026, little changed YoY from $223.0 million in Q1 2025, and little changed on a QoQ basis from $222.4 million in Q4 2025.
Evolus (EOLS) Assets Average (2018 - 2026) Analysis & Trends
Evolus (EOLS) has 9 years of Assets Average data on file, last reported at $223.3 million in Q1 2026.
- Quarterly Assets Average changed 0.13% year-over-year to $223.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $223.3 million (changed 0.13% YoY) and the FY2025 annual result came in at $229.2 million, up 8.75% from the prior year.
- Assets Average held at $223.3 million in Q1 2026, from $222.4 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $239.1 million in Q1 2022 to a low of $164.6 million in Q2 2023.
- A 5-year average of $208.0 million and a median of $221.1 million in 2025 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2023 — Assets Average dropped 29.26% — and 2024, when it soared 39.71%.
- Tracing EOLS's Assets Average over 5 years: stood at $185.4 million in 2022, then fell by 3.7% to $178.5 million in 2023, then increased by 29.47% to $231.1 million in 2024, then fell by 3.75% to $222.4 million in 2025, then advanced by 0.37% to $223.3 million in 2026.
- The last three Assets Average figures came in at $223.3 million (Q1 2026), $222.4 million (Q4 2025), and $223.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Evolus | 550.67 Mn | 505.50 Mn | 57.18 Mn | 234.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 234.34 Mn |
| Mar 31, 2026 | 223.26 Mn |
| Dec 31, 2025 | 222.43 Mn |
| Sep 30, 2025 | 223.90 Mn |
| Jun 30, 2025 | 221.08 Mn |
| Mar 31, 2025 | 222.97 Mn |
| Dec 31, 2024 | 231.09 Mn |
| Sep 30, 2024 | 231.69 Mn |
| Jun 30, 2024 | 229.97 Mn |
| Mar 31, 2024 | 207.59 Mn |
| Dec 31, 2023 | 178.48 Mn |
| Sep 30, 2023 | 168.48 Mn |
| Jun 30, 2023 | 164.61 Mn |
| Mar 31, 2023 | 169.11 Mn |
| Dec 31, 2022 | 185.35 Mn |
| Sep 30, 2022 | 201.82 Mn |
| Jun 30, 2022 | 215.79 Mn |
| Mar 31, 2022 | 239.07 Mn |
| Dec 31, 2021 | 236.35 Mn |
| Sep 30, 2021 | 227.54 Mn |